Welcome to Reddy US Therapeutics, Inc.

Reddy US Therapeutics, Inc. was established in November 1999. We are a subsidiary of Dr. Reddy's Laboratories Limited, Hyderabad, India. Dr. Reddy's Laboratories Limited is a fully integrated pharmaceutical company with a presence in over 100 countries around the globe.

As part of Dr. Reddy's Discovery Research division, we are dedicated to discovering novel therapeutics that address unmet medical needs in diabetes, cardiovascular disease, anti-infectives, inflammation and cancer.

We creatively apply state of the art scientific methods to the rapid discovery and design of therapeutics. Our approach focuses on the regulation of gene expression and the protein function of targets that we have determined to be key effectors of these diseases. Our technology platform, the CMS Pathway™, links cell matrix signaling to endothelial cell function, smooth muscle cell function and disease. The CMS Pathway™ enables us to target several diseases from a single research focus.